Search

Teva Pharmaceutical Industries Ltd.

Closed

SectorHealthcare

36.15 0.31

Overview

Share price change

24h

Current

Min

35.82

Max

36.53

Key metrics

By Trading Economics

Income

-944M

-575M

Sales

161M

4.1B

P/E

Sector Avg

62.593

57.366

EPS

0.64

Profit margin

-13.882

Employees

31,173

EBITDA

-896M

-19M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.12% upside

Market Stats

By TradingEconomics

Market Cap

6.8B

43B

Previous open

35.84

Previous close

36.15

News Sentiment

By Acuity

16%

84%

35 / 340 Healthcare

Teva Pharmaceutical Industries Ltd. Chart

Past performance is not a reliable indicator of future results.

Related News

31 Aug 2026, 23:56 UTC

News

Array Technologies has acquired Affordable Wire Management, enhancing its portfolio and growth potential. Shares are trading slightly higher in after-market hours.

31 Aug 2026, 23:56 UTC

News

Frontier Group Holdings plans to terminate leases for 13 A320neo aircraft, leading to anticipated charges of $60 million to $80 million. Shares are lower in after-market hours.

31 Aug 2026, 23:51 UTC

News

Howmet Aerospace shares are higher in after-market hours following Elon Musk's comments on SpaceX's gas turbine blade plans, sparking renewed interest and improved sentiment.

31 Aug 2026, 23:46 UTC

News

American Water Works shares are trading higher in after-market hours amid a pending merger settlement approval from the Pennsylvania Public Utility Commission.

31 Aug 2026, 23:46 UTC

Correlated Moves
News

Renasant Corp appointed Catherine Mealor as Executive Vice President, effective October 2026. Shares are trading higher in after-market hours following the announcement.

31 Aug 2026, 23:46 UTC

News

IQVIA Holdings Inc shares are higher in after-market trading, remaining above their 20-day moving average amid sector growth expectations despite ongoing challenges.

31 Aug 2026, 23:41 UTC

News

Quantum Corp shares declined in after-market trading amid broader market sentiment affected by hawkish comments from Federal Reserve Chair Kevin Warsh on inflation.

31 Aug 2026, 23:41 UTC

Event
News

Jazz Pharmaceuticals PLC reported positive results from the HERIZON-GEA-01 trial for Ziihera, leading shares higher in after-hours trading.

31 Aug 2026, 23:41 UTC

News

KeyCorp shares are higher in after-market hours following the appointment of Chris Doll as Chief Strategy Officer, effective August 31, 2026.

31 Aug 2026, 23:16 UTC

News

Delek US Holdings Inc. supports Small Refinery Exemptions, enabling increased investments in refineries and U.S. energy infrastructure. Shares are higher in after-market trading.

31 Aug 2026, 23:16 UTC

News

Sylvamo Corp shares are higher in after-market hours, buoyed by strong institutional ownership and earnings per share of $1.88.

31 Aug 2026, 23:11 UTC

Social Media
News

Coinbase Global shares are lower in after-market trading, amid ongoing interest and developments in the crypto space, including Webull's new services in Canada.

31 Aug 2026, 23:11 UTC

News

Under Armour has filed for a mixed shelf offering, including potential debt and equity. Shares traded roughly flat during after-market hours.

31 Aug 2026, 23:11 UTC

News

Northrop Grumman secured an $86.1 million contract extension from the U.S. Department of War, boosting shares higher in after-market trading.

31 Aug 2026, 23:11 UTC

Correlated Moves
News

The USD/PLN is lower today, influenced by comments from Federal Reserve Chair Kevin Warsh regarding potential interest rate hikes amid rising inflation concerns.

31 Aug 2026, 23:06 UTC

News

Oracle Corp is higher in after-market trading, despite challenges including a record low free cash flow yield and concerns about its hyperscaler strategy.

31 Aug 2026, 23:06 UTC

News

Ares Capital Corp raised ¥612 billion for its Japan Logistics Development Partners V LP, exceeding its predecessor's size. Shares are higher in after-market hours.

31 Aug 2026, 23:06 UTC

Social Media
News

KKR & Co Inc. shares are higher in after-market hours following the firm's support for Wella Co's upcoming IPO on the New York Stock Exchange.

31 Aug 2026, 23:06 UTC

News

RTX Corp partners with Lockheed Martin and Tata Advanced Systems for Javelin missile co-production in India. Shares are higher in after-market trading.

31 Aug 2026, 23:06 UTC

Event
News

Eli Lilly shares are higher in after-market trading following regulatory clearance for its merger with AtaiBeckley, marking a key milestone in the process.

31 Aug 2026, 23:06 UTC

News

Johnson & Johnson shares are higher in after-market trading following the announcement of an investor conference call on October 13, 2026, for third-quarter results.

31 Aug 2026, 23:06 UTC

Correlated Moves
News

The USD/NOK is trading lower, reflecting a decline since Friday. Market sentiment shifts after comments from Federal Reserve Chair Kevin Warsh on inflation and interest rates.

31 Aug 2026, 23:06 UTC

News
Correlated Moves

Geopolitical tensions and hawkish Fed remarks are supporting gains in CAD/HKD, which is trading near the upper end of its one-month range.

31 Aug 2026, 23:06 UTC

Correlated Moves
News

The USD/SGD is lower today, influenced by Federal Reserve comments on inflation and rising Treasury yields. The pair remains near its one-month range's lower end.

31 Aug 2026, 23:01 UTC

News

Global Water Resources Inc shares lower after announcing a $0.03 dividend, with analysts projecting earnings of $0.13 per share next year.

31 Aug 2026, 23:01 UTC

News

Align Technology shares are lower in after-market trading following the appointment of Quentin Blackford to its Board of Directors, effective immediately.

31 Aug 2026, 23:01 UTC

News

elf Beauty Inc shares are lower in after-market trading amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh.

31 Aug 2026, 23:01 UTC

News

Charter Communications shares are lower in after-market hours following the announcement of CFO Jessica Fischer's resignation effective October 15, 2026.

31 Aug 2026, 23:01 UTC

News

Avista Corp seeks to reduce natural gas rates by about 11.5%, potentially lowering bills by $7.38. Shares advanced in after-market trading.

31 Aug 2026, 23:01 UTC

Social Media
News

Evercore upgraded Duolingo to Outperform, raising its price target to $210. Shares rose after market close, reflecting positive sentiment around the stock.

Peer Comparison

Price change

Teva Pharmaceutical Industries Ltd. Forecast

Price Target

By TipRanks

15.12% upside

12 Months Forecast

Average 41.5 USD  15.12%

High 44 USD

Low 40 USD

Based on 7 Wall Street analysts offering 12 month price targets forTeva Pharmaceutical Industries Ltd. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Sentiment

By Acuity

35 / 340 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
help-icon Live chat